Anne Leselbaum

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

Julián Panés, Damián García‐Olmo, Gert Van Assche et al. · The Lancet · 2016 · 1K citations

Regenerative Medicine, Inflammation, Complex Perianal Fistulas +8

Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease

Julián Panés, Damián García‐Olmo, Gert Van Assche et al. · Gastroenterology · 2017 · 470 citations

Stem Cell Therapy, Long-term Efficacy, Gastroenterology +9

Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study

Dave Singh, Paul Jones, Eric Bateman et al. · BMC Pulmonary Medicine · 2014 · 172 citations · Full text

Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study

Anthony D’Urzo, Stephen I. Rennard, Edward Kerwin et al. · Respiratory Research · 2014 · 145 citations · Full text

Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)

Eric Bateman, Kenneth R. Chapman, Dave Singh et al. · Respiratory Research · 2015 · 114 citations · Full text